HOME >> BIOLOGY >> NEWS
Wistar Scientist Awarded US Army Prostate Cancer Research Program Grant

Philadelphia -- George C. Prendergast, Ph.D., a scientist in The Wistar Institute's Molecular Genetics Program, has been awarded a $491,000 US Army Prostate Cancer Research Program grant for research into a possible new diagnostic and prognostic marker for prostate cancer.

An intriguing set of data accumulated in Dr. Prendergast's laboratory suggests that a new prostate cancer suppressor gene, called Bin1, may accumulate in aggressive malignant cells but not in non-threatening or normal prostate cells. "If that is true," explains Dr. Prendergast, "Bin1 could be a molecular marker that identifies aggressive cancers of the prostate and makes it possible to predict the risk of each prostate cancer patient."

Bin1 was discovered because of its ability to interact with and inhibit the transforming potential of Myc, a cancer causing protein that is often activated in a wide variety of human cancers, including prostate carcinoma. Myc is of particular interest because it not only promotes malignant cell growth, but also, under certain conditions, can activate cell suicide.

"We identified Bin1 as part of an effort to learn how this Myc 'booby trap' might be sprung in cancer cells to kill them," says Dr. Prendergast. "Our recent results support our hypothesis that Bin1 controls Myc's killing activity."

The Wistar Institute, established in 1892, was the first independent medical research facility in the country. For more than 100 years, Wistar scientists have been making history and improving world health through their development of vaccines for diseases that include rabies, German measles, infantile gastroenteritis (rotavirus), and cytomegalovirus; discovery of molecules like interleukin-12, which are helping the immune system fight bacteria, parasites, viruses and cancer; and location of genes that contribute to the development of diseases like breast, lung and prostate cancer. Wistar is a National Cancer Institute Cancer Center.


'"/>

Contact: Diana Cutshall
dcutshall@wista.wistar.upenn.edu
(215) 898-3716
The Wistar Institute
20-May-1998


Page: 1

Related biology news :

1. Wistar-discovered antibody will help diagnose appendicitis
2. 2004 Wistar Institute Science Journalism Award winners announced
3. Call for Entries: The 2004 Wistar Institute Science Journalism Award
4. Wistar-developed antibody shows promise against brain tumors in Drexel trial
5. Wistar study offers new support for a histone code theory of gene regulation
6. Regeneration in the mammalian heart demonstrated by Wistar researchers
7. Wistar scientists add difficult-to-sequence stretches to human genome data
8. Wistar scientist receives award from National Cancer Institute
9. Director of Emory Vaccine Center to give Wistar Institutes 1999 Tadeusz J. Wiktor Memorial lecture
10. Wistar scientists find striking similarities between bacterial virus and human adenovirus
11. Wistar Institute scientists find key piece in gene regulation puzzle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... ... hM4Di ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello ... and the National Institute of Neurological Disorders and Stroke, both institutes of the ...
(Date:2/27/2019)... ... 2019 , ... Fluxion Biosciences, a leading developer of precision solutions for life ... grant for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant ... Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... precision medicine, the traditional line between engineering and medical science grows ever thinner. ... smarter, the medical device industry is making medical practice easier for doctors, more ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... in Israel and the Middle East region, and Swiss-based CDMO Lonza announced ... platform. The partnership will enable Sheba to vastly streamline its in-house cell ...
(Date:3/14/2019)... PRINCETON, N.J. (PRWEB) , ... March 14, 2019 , ... ... will create challenges for companies to keep up. Traditional Regulatory intelligence ... times and adapting technology to get global Regulatory teams right Insights faster and cheaper. ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
Breaking Biology Technology:
Cached News: